cache/ba799388c38daff8b64246b3babfc0fb0fbe0d90af01ce7bb7af8c013e038002

COM:QURE4U

Qure4u

  • Privately Held

Company Overview

Metric
Company NameQure4uAxoniEQS Group AG
SymbolEQS
MSH IDCOM:QURE4UCOM:AXONICOM:EQS
MarketPRIVATEPRIVATESTOCKS
SectorHealthcare & Health ServicesFinancial ServicesIndustrials
IndustryHealthcare TechnologyTechnologySpecialty Business Services
CountryUSUSDE
StageVenture Round
Employee Count41101522
Websitequre4u.comaxoni.comeqs.com
LinkedInqure4uaxonieqs-group
Founders

Market Metrics

Metric
Market Cap421.39M
Enterprise Value
Monthly Web Traffic3.50K155.45K
Web Traffic Growth0.100.27
Valuation
Raised Capital20M

Financial Performance

Metric
Revenue73.30M
Revenue (LTM)
Revenue (NTM)
Gross Profit13.54M
EBITDA3.46M
Operating Income-5.45M
Net Income-6.39M
EPS-0.63
Diluted EPS-0.63
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.38
Operating Profit Margin-0.02
EBITDA Margin0.05
Net Profit Margin-0.04
Return on Equity-0.03
Return on Assets-0.02
Return on Capital Employed-0.01

Valuation Multiples

Metric
P/E Ratio-136.96
P/B Ratio3.63
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio6.05
EV Multiple105.25

Operational Metrics

Metric
Days Sales Outstanding
Days Payables Outstanding24.01
Days Inventory Outstanding0.00
Operating Cycle41.70
Cash Conversion Cycle8.15
Asset Turnover0.38

Cash Flow Metrics

Metric
Operating Cash Flow7.60M
Free Cash Flow4.97M
Cash Flow to Debt0.28
Operating Cash Flow/Sales0.14
Free Cash Flow Yield0.02

Balance Sheet Metrics

Metric
Cash & Equivalents7.93M
Accounts Receivable-2.28M
Inventory
Goodwill103.14M
Debt to Capitalization0.24
Debt to Assets
Current Ratio0.59
Quick Ratio0.52

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue